由于A型流感 (H1N1) 与黄金葡萄球菌的同时感染而引起的死性肺炎:一个病例报告
Huibin Chen1, Hui Duan1, Jinling Zhao1
1Department of Intensive Medicine, the First Affiliated Hospital of Kunming Medical University, Kumming 650032, Yunnan, China.
IDCases
|September 12, 2024
概括
与A型流感 (H1N1) 和黄金葡萄球菌 (Staphylococcus aureus) 的同时感染,特别是具有毒性因子的菌株,可以导致严重的死性肺炎和毒性休克综合征. 这一案例凸显了在识别和治疗成人这种危及生命的共同感染时的警的必要性.
科学领域:
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
- 微生物学 微生物学
背景情况:
- 社区获得的性肺炎和毒性休克综合征是严重的疾病.
- 流感A (H1N1) 和黄金葡萄球菌联合感染对临床提出了重大挑战.
- 黄金葡萄球菌的毒性因素,如LukS-PV和LukF-PV,可以加剧疾病的严重程度.
关键词:
同时感染 同时感染流感病毒A (H1N1) 病毒这两种基因是LukF和LukS基因.死性肺炎是一种肺炎.潘顿瓦伦丁白素 (PVL) 产生的金黄色葡萄球菌.肺炎是一种肺炎.毒性休克综合征是一种毒性休克综合征.更多相关视频
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
2.4K
00:13A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
5.6K
相关概念视频
01:30Pneumonia I: Introduction
214
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
01:29Pneumonia II: Pathophysiology
233
The pathophysiology of pneumonia involves the following steps:
233
01:30Pneumonia III: Complications and Assessment
188
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
188
01:28Pneumonia IV: Management
309
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
309